Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.

Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.

<h4>Background</h4>We undertook a study to evaluate the clinical relevance of miR-92a in plasma obtained from non-Hodgkin's lymphoma (NHL) patients, because the miR-17-92 polycistronic miRNA cluster plays a crucial role in lymphomagenesis and affects neo-angiogenesis.<h4>Metho...

Full description

Bibliographic Details
Main Authors:	Kazuma Ohyashiki, Tomohiro Umezu, Sei-Ichiro Yoshizawa, Yoshikazu Ito, Michiyo Ohyashiki, Hisashi Kawashima, Masami Tanaka, Masahiko Kuroda, Junko H Ohyashiki
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-02-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21383985/?tool=EBI

Similar Items

Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a
by: Tanaka Masami, et al.
Published: (2010-12-01)

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients.
by: Masami Tanaka, et al.
Published: (2009-01-01)

Age-related decrease of miRNA-92a levels in human CD8<sup>+ </sup>T-cells correlates with a reduction of naïve T lymphocytes
by: Ohyashiki Michiyo, et al.
Published: (2011-11-01)

The C allele of <it>JAK2 </it>rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population
by: Ohyashiki Junko H, et al.
Published: (2012-01-01)

Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells
by: Satoshi Imanishi, et al.
Published: (2018-10-01)

Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation
by: Seiichiro Yoshizawa, et al.
Published: (2018-08-01)

A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells
by: Yu Zhang, et al.
Published: (2008-10-01)

Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib
by: Kazuma Ohyashiki, et al.
Published: (2016-04-01)

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely
by: Ohyashiki JH, et al.
Published: (2014-08-01)

Expression Profile of a γ-Deletion Variant of the Human Telomerase Reverse Transcriptase Gene
by: Hisashi Hisatomi, et al.
Published: (2003-05-01)

A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome
by: Asano M, et al.
Published: (2019-05-01)

Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
by: Tanaka Yuko, et al.
Published: (2011-08-01)

Low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia
by: Seiichiro Katagiri, et al.
Published: (2017-01-01)

Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemia.
by: Seiichi Okabe, et al.
Published: (2014-01-01)

Hodgkin's lymphoma
by: E. A. Demina, et al.
Published: (2020-06-01)

Hodgkin's Lymphoma
Published: (2012)

Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas.
by: Dharma R Thapa, et al.
Published: (2011-01-01)

Composite Lymphoma: Hodgkin and Non-Hodgkin Lymphoma A Case Report
by: Noorwati Soetandyo, et al.
Published: (2018-09-01)

Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma
by: Sun Hee Chang, et al.
Published: (2015-01-01)

Pathobiology of Hodgkin Lymphoma
by: Pier Paolo Piccaluga, et al.
Published: (2011-01-01)

Cutaneous Hodgkin's lymphoma
by: Asawari Anant Ambekar, et al.
Published: (2017-01-01)

EBV IN HODGKIN LYMPHOMA
by: Stefan Hohaus, et al.
Published: (2009-11-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

NON-HODGKIN'S LYMPHOMA
by: Sajjad Ahmad Baloch
Published: (2015-01-01)

EBV IN HODGKIN LYMPHOMA
by: Giuseppina Massini, et al.
Published: (2009-11-01)

Hodgkin Lymphoma : Studies of Advanced Stages, Relapses and the Relation to Non-Hodgkin Lymphomas
by: Amini, Rose-Marie
Published: (2002)

Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
by: Hadis Kiani, et al.
Published: (2016-05-01)

Transplantation of Hodgkin's and non-Hodgkin's lymphomas into SCID mice
by: Lowrey, Jacqueline Anne
Published: (1996)

Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome
by: Krischan Braitsch, et al.
Published: (2018-10-01)

Hodgkin's Lymphoma in Children and Adolescents: A Saint Petersburg Hodgkin's Lymphoma Group Study
by: Svetlana A. Kulyova, et al.
Published: (2011-01-01)

The role of autophagy in Hodgkin lymphoma
by: Hui-ChenLin, et al.
Published: (2018)

Immunotherapies in Non-Hodgkin’s Lymphoma
by: Christine Bezombes, et al.
Published: (2021-07-01)

ORBITAL NON-HODGKIN’S LYMPHOMAS
by: S. V. Saakyan, et al.
Published: (2015-04-01)

Epidemiology of Non-Hodgkin’s Lymphoma
by: Krishna C. Thandra, et al.
Published: (2021-01-01)

Genomic Landscape of Hodgkin Lymphoma
by: Magdalena M. Brune, et al.
Published: (2021-02-01)

Primary pulmonary Hodgkin lymphoma
by: Shumaila Tanveer, et al.
Published: (2015-12-01)

Dural non-Hodgkin’s lymphomas
by: L G Babicheva, et al.
Published: (2016-06-01)

Surgery for non-Hodgkin’s lymphoma
by: Elroy Patrick Weledji, et al.
Published: (2015-07-01)

Primary adrenal Hodgkin lymphoma
by: Tarek Haykal, et al.
Published: (2019-03-01)

Hodgkin's Lymphoma with Cutaneous Involvement
by: Ahmad Ameri, et al.
Published: (2016-10-01)

Cannot write session to /tmp/vufind_sessions/sess_aj2fmnocr5gvdroe4agh6i5nv4